SAR-442257
SAR442257 is a humanized IgG4-S228P, kappa monoclonal antibody targeting CD38 and CD28 on multiple myeloma cells and co-stimulates CD3 and CD28 on T cells[1].
Product Specifications
UNSPSC
12352203
Target
CD28; CD3; CD38
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
99.0
Smiles
[*]S[R442257]
Molecular Weight
(145.44 kDa)
References & Citations
[1]Grab AL, et al. Pre-Clinical Assessment of SAR442257, a CD38/CD3xCD28 Trispecific T Cell Engager in Treatment of Relapsed/Refractory Multiple Myeloma. Cells. 2024 May 20;13 (10) :879.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
038736-APC 200 µL
MYL6, ID (MYL6, Myosin light polypeptide 6, 17kD myosin light chain, Myosin light chain 3, Myosin light chain alkali 3, Smooth muscle and nonmuscle myosin light chain alkali 6) (APC) discontinued
Sign In for Pricing
View Details 